Wellcome Sanger Institute Increases Investment in PacBio Long-Read Sequencing to Support Darwin Tree of Life Research Initiative
08 janv. 2021 08h00 HE
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif ., Jan. 08, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality, long-read sequencing platforms, today announced that...
Pacific Biosciences Grants Equity Incentive Award to New Employee
18 déc. 2020 16h05 HE
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Dec. 18, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality sequencing...
SARS-CoV-2 Viral Genome Sequencing Data Presented from Research Using Pacific Biosciences Technology
16 déc. 2020 08h00 HE
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Dec. 16, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes,...
Leading UK Core Labs Expand Investment in PacBio Sequencing Systems to Power Life Science Research with HiFi Reads
14 déc. 2020 08h00 HE
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Dec. 14, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes,...
Pacific Biosciences of California, Inc. Announces Pricing of Public Offering of Common Stock
11 nov. 2020 00h21 HE
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Nov. 11, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB) (“Pacific Biosciences” or the “Company”) today announced that it has priced its...
Pacific Biosciences of California, Inc. Announces Proposed Public Offering of Common Stock
10 nov. 2020 16h05 HE
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB) today announced that it intends to offer and sell $85.0 million of shares of its common...
Pacific Biosciences of California, Inc. Announces Third Quarter 2020 Financial Results
02 nov. 2020 16h02 HE
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for its third quarter ended September 30, 2020. ...
Invitae and Pacific Biosciences Collaborate to Develop Whole Genome Sequencing-Based Assays for Pediatric Epilepsy Diagnostics
22 oct. 2020 08h00 HE
|
Pacific Biosciences of California, Inc.
SAN FRANCISCO and MENLO PARK, Calif., Oct. 22, 2020 (GLOBE NEWSWIRE) -- Invitae Corporation (NYSE: NVTA), a leading genetics company, and Pacific Biosciences of California, Inc. (Nasdaq:PACB), a...
Pacific Biosciences of California, Inc. Third Quarter 2020 Financial Results Call
19 oct. 2020 12h30 HE
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Oct. 19, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its Third Quarter 2020 Financial...
Children’s Mercy Kansas City Teams Up with Pacific Biosciences to Fight Rare Disease
15 oct. 2020 08h00 HE
|
Pacific Biosciences of California, Inc.; Children’s Mercy Kansas City
KANSAS CITY, Mo., and MENLO PARK, Calif., Oct. 15, 2020 (GLOBE NEWSWIRE) -- Children’s Mercy Kansas City, one of the nation’s top pediatric medical systems, and Pacific Biosciences of California,...